Trial intelligence / Profile preview

Xylocaine Impregnated Compress for Pain Reduction During Trigger Finger Infiltration

NCT05032508Phase 4Completed

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Jun 2022
Primary completion
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lidocaine 10% oropharyngeal spray in trigger finger, sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2022; status: completed.

02

Drugs

lidocaine 10% oropharyngeal spray
03

Conditions

trigger finger

Beyond the preview

Go deeper on NCT05032508.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05032508.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call